DE69328846D1 - Zellfixierungsmittel und Verfahren zum Anfärben von Zellen ohne Vernichtung der Zelloberfläche - Google Patents

Zellfixierungsmittel und Verfahren zum Anfärben von Zellen ohne Vernichtung der Zelloberfläche

Info

Publication number
DE69328846D1
DE69328846D1 DE69328846T DE69328846T DE69328846D1 DE 69328846 D1 DE69328846 D1 DE 69328846D1 DE 69328846 T DE69328846 T DE 69328846T DE 69328846 T DE69328846 T DE 69328846T DE 69328846 D1 DE69328846 D1 DE 69328846D1
Authority
DE
Germany
Prior art keywords
cell
cellular
fixative
components
fixative composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69328846T
Other languages
English (en)
Other versions
DE69328846T2 (de
Inventor
Mark Carle Connelly
Brooks, Jr
Utpal R Chakraborty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ortho Clinical Diagnostics Inc
Original Assignee
Ortho Diagnostic Systems Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Diagnostic Systems Inc filed Critical Ortho Diagnostic Systems Inc
Application granted granted Critical
Publication of DE69328846D1 publication Critical patent/DE69328846D1/de
Publication of DE69328846T2 publication Critical patent/DE69328846T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • G01N33/56988HIV or HTLV
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56966Animal cells
    • G01N33/56972White blood cells
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56983Viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis
    • G01N2001/305Fixative compositions
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00Chemistry: molecular biology and microbiology
    • Y10S435/975Kit
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10STECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00Chemistry: analytical and immunological testing
    • Y10S436/805Optical property
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/101666Particle count or volume standard or control [e.g., platelet count standards, etc.]
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/10Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
    • Y10T436/108331Preservative, buffer, anticoagulant or diluent
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00Chemistry: analytical and immunological testing
    • Y10T436/25Chemistry: analytical and immunological testing including sample preparation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Pathology (AREA)
  • General Physics & Mathematics (AREA)
  • General Health & Medical Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • AIDS & HIV (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Peptides Or Proteins (AREA)
  • Detergent Compositions (AREA)
DE69328846T 1992-03-27 1993-03-26 Zellfixierungsmittel und Verfahren zum Anfärben von Zellen ohne Vernichtung der Zelloberfläche Expired - Lifetime DE69328846T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/859,212 US5422277A (en) 1992-03-27 1992-03-27 Cell fixative composition and method of staining cells without destroying the cell surface

Publications (2)

Publication Number Publication Date
DE69328846D1 true DE69328846D1 (de) 2000-07-20
DE69328846T2 DE69328846T2 (de) 2000-11-09

Family

ID=25330350

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69328846T Expired - Lifetime DE69328846T2 (de) 1992-03-27 1993-03-26 Zellfixierungsmittel und Verfahren zum Anfärben von Zellen ohne Vernichtung der Zelloberfläche

Country Status (9)

Country Link
US (2) US5422277A (de)
EP (1) EP0562877B1 (de)
JP (1) JP3651912B2 (de)
AT (1) ATE193944T1 (de)
CA (1) CA2092866C (de)
DE (1) DE69328846T2 (de)
DK (1) DK0562877T3 (de)
ES (1) ES2148202T3 (de)
GR (1) GR1002073B (de)

Families Citing this family (101)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5422277A (en) * 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
WO1994007138A1 (en) * 1992-09-14 1994-03-31 Fodstad Oystein Detection of specific target cells in specialized or mixed cell population and solutions containing mixed cell populations
GB9223035D0 (en) * 1992-11-03 1992-12-16 Kiessling Cooper Ann A Preservation of peripheral blood & semen in fixatives that inactivate human pathogens
EP0598663B1 (de) * 1992-11-19 2000-02-02 Sysmex Corporation Verfahren zur Vorbehandlung für Blutanalyse
DZ1781A1 (fr) * 1993-05-21 2002-02-17 Radopah Ltd Agents d'arylation.
BR9407003A (pt) * 1993-07-05 1996-03-26 North Gen Hospital Nhs Trust Preparaçao e estabilizaçao de células
DE4343461C1 (de) * 1993-12-20 1995-06-14 Erno Raumfahrttechnik Gmbh Verfahren zur Fixierung biologischer Präparate
NO180658C (no) 1994-03-10 1997-05-21 Oeystein Fodstad Fremgangsmåte og anordning for deteksjon av spesifikke målceller i spesialiserte eller blandede cellepopulasjoner og opplösninger som inneholder blandede cellepopulasjoner
DK0754301T3 (da) * 1994-04-05 1999-06-07 North Gen Hospital Nhs Trust Fremstilling og stabilisering af cellesuspensioner
US5648222A (en) * 1994-07-27 1997-07-15 The Trustees Of Columbia University In The City Of New York Method for preserving cells, and uses of said method
US5648220A (en) * 1995-02-14 1997-07-15 New England Medical Center Hospitals, Inc. Methods for labeling intracytoplasmic molecules
NO961031D0 (no) 1996-03-13 1996-03-13 Det Norske Radiumshospital Tum Fremgangsmåte til å drepe uönskede målceller
EP0834742A1 (de) * 1996-10-01 1998-04-08 Gull Laboratories GmbH Spezifischer Anti-EBNA-1-Test mittels antikomplementärer Immunfluoreszenz
US7521176B2 (en) * 1996-10-15 2009-04-21 Theranostech, Inc. Methods for characterizing the viral infectivity status of a host
US5811303A (en) * 1997-04-01 1998-09-22 Streck Laboratories, Inc. Quantitative buffy coat control composition
GB9716454D0 (en) * 1997-08-05 1997-10-08 Univ St Andrews Polymer
US6793890B2 (en) 1997-08-20 2004-09-21 The University Of Miami Rapid tissue processor
ATE407353T1 (de) 1997-08-20 2008-09-15 Univ Miami Hochqualitatives durchlaufendes verfahren zur fixierung, dehydratisierung, entfettung und imprägnation von geweben
US6664045B1 (en) * 1998-06-18 2003-12-16 Boston Probes, Inc. PNA probes, probe sets, methods and kits pertaining to the detection of microorganisms
CN1144034C (zh) * 1998-06-30 2004-03-31 莱密纳股份有限公司 细胞学和组织学固定剂组合物及其使用方法
US6280946B2 (en) * 1998-08-07 2001-08-28 Boston Probes, Inc. PNA probes, probe sets, methods and kits pertaining to the universal detection of bacteria and eucarya
US6143512A (en) * 1998-08-17 2000-11-07 Markovic; Nenad Cap-pap test
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
US6916608B2 (en) * 1999-09-10 2005-07-12 Becton, Dickinson And Company Composition for providing long term stability to cells for diagnostic testing
US20010016317A1 (en) * 1999-09-13 2001-08-23 Dolores M. Berger Method for providing long term stability to cells for diagnostic testing
NL1015352C2 (nl) * 2000-05-31 2001-12-03 Charles Edward Strother Iii Antigen conjugatie vaccinatie techniek met gastheer virus.
EP1301796A2 (de) * 2000-07-04 2003-04-16 BioImage A/S Verfahren zur ableitung quantitativer informationen über interaktionen zellulärer komponenten
US6828109B2 (en) * 2000-12-15 2004-12-07 James R. Bell, Jr. Methods for detecting an analyte of interest using catalyzed reporter deposition of tyramide
GB0111442D0 (en) * 2001-05-10 2001-07-04 Isis Innovation Method for preparing recombinant virus
US20030228635A1 (en) * 2002-02-15 2003-12-11 Renovar, Inc. Cell proliferation assays and methods
US7138226B2 (en) 2002-05-10 2006-11-21 The University Of Miami Preservation of RNA and morphology in cells and tissues
CA2428740A1 (en) * 2002-05-20 2003-11-20 Bayer Corporation Automated method and reagent therefor for assaying body fluid samples such as cerebrospinal fluid (csf)
DE60308259T2 (de) * 2002-05-22 2007-04-05 Sysmex Corp. Immunologische Verfahren, Vorrichtungen und Reagenzien
DE10305768A1 (de) * 2003-02-11 2004-08-19 Justus-Liebig-Universität Giessen Verfahren zum Färben von lipophilen Zellbestandteilen einer biologischen Probe
US7041481B2 (en) * 2003-03-14 2006-05-09 The Regents Of The University Of California Chemical amplification based on fluid partitioning
US7267980B1 (en) 2003-04-04 2007-09-11 Research & Diagnostic Systems, Inc. Stabilizing solution for cells and tissues
US20040197836A1 (en) * 2003-04-04 2004-10-07 Hashemi Brian B. Measurement of F-actin in whole blood cellular subsets
US20050069958A1 (en) * 2003-09-26 2005-03-31 Mills Rhonda A. Method for simultaneous evaluation of a sample containing a cellular target and a soluble analyte
US7326577B2 (en) * 2003-10-20 2008-02-05 Esoterix, Inc. Cell fixation and use in phospho-proteome screening
US8507277B2 (en) 2003-10-24 2013-08-13 Gencia Corporation Nonviral vectors for delivering polynucleotides
ES2411962T3 (es) 2003-10-24 2013-07-09 Gencia Corporation Métodos y composiciones para suministrar polinucleótidos
DK1676117T3 (da) 2003-10-24 2009-11-09 Univ Miami Simplificeret forarbejdning af væv
US20090208478A1 (en) * 2003-10-24 2009-08-20 Gencia Corporation Transducible polypeptides for modifying metabolism
US20090123468A1 (en) 2003-10-24 2009-05-14 Gencia Corporation Transducible polypeptides for modifying metabolism
US8062891B2 (en) 2003-10-24 2011-11-22 Gencia Corporation Nonviral vectors for delivering polynucleotides to plants
US8133733B2 (en) 2003-10-24 2012-03-13 Gencia Corporation Nonviral vectors for delivering polynucleotides to target tissues
US20050266503A1 (en) * 2004-05-24 2005-12-01 Esoterix, Inc. Simultaneous assay of target and target-drug binding
US7803523B2 (en) * 2004-08-27 2010-09-28 University Health Network Whole blood preparation for cytometric analysis of cell signaling pathways
WO2006090096A1 (en) * 2005-02-28 2006-08-31 Sheffield Teaching Hospitals Nhs Foundation Trust Composition, kit and method for fixing cells
WO2007016379A2 (en) * 2005-07-28 2007-02-08 Id-Fish Technology, Inc. Method for improving cell permeability to foreign particles
US8758990B2 (en) * 2005-07-28 2014-06-24 Id-Fish Technology, Inc. Methods for detecting and differentiating Mycobacterium genus and Mycobacterium avium complex in a sample or culture
DE102006040315B4 (de) * 2006-08-29 2008-06-05 Biosepar -Gesellschaft für Medizin- und Labortechnik mbH Fixativum zum Fixieren von biologischen Materialien
US20090269800A1 (en) * 2008-04-29 2009-10-29 Todd Covey Device and method for processing cell samples
US20090298172A1 (en) 2008-05-28 2009-12-03 Steven Paul Wheeler Histological specimen treatment apparatus and method
WO2010006303A2 (en) * 2008-07-10 2010-01-14 Nodality, Inc. Methods and apparatus related to management of experiments
US20100014741A1 (en) * 2008-07-10 2010-01-21 Banville Steven C Methods and apparatus related to gate boundaries within a data space
US9183237B2 (en) 2008-07-10 2015-11-10 Nodality, Inc. Methods and apparatus related to gate boundaries within a data space
US20100030719A1 (en) * 2008-07-10 2010-02-04 Covey Todd M Methods and apparatus related to bioinformatics data analysis
US7968279B2 (en) * 2008-08-13 2011-06-28 Beckman Coulter, Inc. Reference control for cell by cell analysis
US20100086951A1 (en) * 2008-09-04 2010-04-08 Beckman Coulter, Inc. Pan-Kinase Activation and Evaluation of Signaling Pathways
US9764322B2 (en) 2008-09-23 2017-09-19 Bio-Rad Laboratories, Inc. System for generating droplets with pressure monitoring
US9598725B2 (en) 2010-03-02 2017-03-21 Bio-Rad Laboratories, Inc. Emulsion chemistry for encapsulated droplets
US8709762B2 (en) 2010-03-02 2014-04-29 Bio-Rad Laboratories, Inc. System for hot-start amplification via a multiple emulsion
US9156010B2 (en) 2008-09-23 2015-10-13 Bio-Rad Laboratories, Inc. Droplet-based assay system
WO2011120006A1 (en) 2010-03-25 2011-09-29 Auantalife, Inc. A Delaware Corporation Detection system for droplet-based assays
US9417190B2 (en) 2008-09-23 2016-08-16 Bio-Rad Laboratories, Inc. Calibrations and controls for droplet-based assays
US10512910B2 (en) 2008-09-23 2019-12-24 Bio-Rad Laboratories, Inc. Droplet-based analysis method
US9132394B2 (en) 2008-09-23 2015-09-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
WO2011120024A1 (en) 2010-03-25 2011-09-29 Quantalife, Inc. Droplet generation for droplet-based assays
US11130128B2 (en) 2008-09-23 2021-09-28 Bio-Rad Laboratories, Inc. Detection method for a target nucleic acid
US8663920B2 (en) 2011-07-29 2014-03-04 Bio-Rad Laboratories, Inc. Library characterization by digital assay
US8951939B2 (en) 2011-07-12 2015-02-10 Bio-Rad Laboratories, Inc. Digital assays with multiplexed detection of two or more targets in the same optical channel
US8633015B2 (en) 2008-09-23 2014-01-21 Bio-Rad Laboratories, Inc. Flow-based thermocycling system with thermoelectric cooler
US9492797B2 (en) 2008-09-23 2016-11-15 Bio-Rad Laboratories, Inc. System for detection of spaced droplets
US9034257B2 (en) * 2008-10-27 2015-05-19 Nodality, Inc. High throughput flow cytometry system and method
US20100233733A1 (en) * 2009-02-10 2010-09-16 Nodality, Inc., A Delaware Corporation Multiple mechanisms for modulation of the pi3 kinase pathway
EP2473618B1 (de) 2009-09-02 2015-03-04 Bio-Rad Laboratories, Inc. System zum mischen von flüssigkeiten durch gerinnung mehrerer emulsionen
CA2767114A1 (en) 2010-03-25 2011-09-29 Bio-Rad Laboratories, Inc. Droplet transport system for detection
CA2793959C (en) 2010-03-25 2019-06-04 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
WO2012061444A2 (en) 2010-11-01 2012-05-10 Hiddessen Amy L System for forming emulsions
WO2012065004A2 (en) * 2010-11-12 2012-05-18 Incelldx, Inc. Methods and systems for predicting whether a subject has a cervical intraepithelial neoplasia (cin) lesion from a suspension sample of cervical cells
JP2014509865A (ja) 2011-03-18 2014-04-24 バイオ−ラッド・ラボラトリーズ・インコーポレーテッド シグナルの組合せ使用による多重化デジタルアッセイ
EP3789498A1 (de) 2011-04-25 2021-03-10 Bio-rad Laboratories, Inc. Verfahren zur nukleinsäureanalyse
JP6177764B2 (ja) 2011-05-02 2017-08-09 ラペンナー ジョゼ カルロス 生物学的試料の固定および保存のための固定液
CA2832109C (en) 2011-06-10 2021-07-06 Oregon Health & Science University Cmv glycoproteins and recombinant vectors
AU2012216792A1 (en) 2011-09-12 2013-03-28 International Aids Vaccine Initiative Immunoselection of recombinant vesicular stomatitis virus expressing HIV-1 proteins by broadly neutralizing antibodies
EP2586461A1 (de) 2011-10-27 2013-05-01 Christopher L. Parks Von einem eingehüllten Virus abgeleitete Virenpartikel
EP3104177B1 (de) * 2011-12-21 2020-11-25 Beckman Coulter, Inc. Verfahren zur markierung intrazellulärer und extrazellulärer targets von leukozyten
WO2013155531A2 (en) 2012-04-13 2013-10-17 Bio-Rad Laboratories, Inc. Sample holder with a well having a wicking promoter
EP2679596B1 (de) 2012-06-27 2017-04-12 International Aids Vaccine Initiative HIV-1 Env-proteinvariante
WO2014185151A1 (ja) * 2013-05-13 2014-11-20 コニカミノルタ株式会社 細胞染色方法及びその方法に使用する検体採取管
US20150065381A1 (en) 2013-09-05 2015-03-05 International Aids Vaccine Initiative Methods of identifying novel hiv-1 immunogens
EP2873423B1 (de) 2013-10-07 2017-05-31 International Aids Vaccine Initiative Lösliche hiv-1-hüllglykoproteintrimere
US9733162B2 (en) 2014-02-11 2017-08-15 Ihor Turkevych Universal system, method and solution for the acceleration of the process of fixing, dehydrating and clearing the structure of biological tissue
US10174292B2 (en) 2015-03-20 2019-01-08 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US9931394B2 (en) 2015-03-23 2018-04-03 International Aids Vaccine Initiative Soluble HIV-1 envelope glycoprotein trimers
US10006084B2 (en) 2015-04-30 2018-06-26 Sakura Finetek U.S.A., Inc. Methods to reduce evaporation during elevated temperature
US10365189B2 (en) 2015-05-07 2019-07-30 Steven Wheeler Histological specimen treatment
US9835527B2 (en) 2015-12-30 2017-12-05 Sakura Finetek U.S.A., Inc. Tissue processing reagent
US10107727B2 (en) 2015-12-30 2018-10-23 Sakura Finetek U.S.A., Inc. Tissue processing reagent
US10945428B2 (en) * 2016-03-04 2021-03-16 Menarini Silicon Biosystems S.P.A. Preservation of cellular components from cells with a preservative

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU552538A1 (ru) * 1973-07-31 1977-03-30 Кубанский Государственный Медицинский Институт Им. Красной Армии Способ вы влени свободного цитоплазматического катионного белка лейкоцитов в микроскопических препаратах
US4423153A (en) * 1981-12-03 1983-12-27 Board Of Regents, The University Of Texas System Methods and compositions for the detection and determination of cellular DNA
US4499183A (en) * 1982-12-21 1985-02-12 Ortho Diagnostic Systems Inc. Detecting intracellular antigens in swelled and fixed cells with labeled antibody
JPS6161055A (ja) * 1984-08-31 1986-03-28 Shionogi & Co Ltd ウイルス赤血球凝集反応試験用鳥類固定赤血球の保存液
US4575452A (en) * 1984-09-21 1986-03-11 E. I. Du Pont De Nemours And Company Kit for silver staining proteins and nucleic acids
GB2192712B (en) * 1986-06-10 1990-02-14 Lab Supplies And Instr Fixative
US4698312A (en) * 1986-07-28 1987-10-06 Fisher Scientific Company Stabilizing blood cells with aromatic polyaldehyde for use in hematology controls and calibrators
JPH06100596B2 (ja) * 1986-09-10 1994-12-12 東亜医用電子株式会社 フロ−サイトメトリ−による白血球の分類方法
DE3824936A1 (de) * 1988-06-28 1990-03-22 Schubert Werner Schnellfixierung
US5422277A (en) * 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface

Also Published As

Publication number Publication date
GR1002073B (en) 1995-12-04
CA2092866C (en) 2007-06-26
GR930100119A (el) 1993-11-30
CA2092866A1 (en) 1993-09-28
EP0562877A3 (en) 1993-12-29
ATE193944T1 (de) 2000-06-15
ES2148202T3 (es) 2000-10-16
DE69328846T2 (de) 2000-11-09
JPH0678792A (ja) 1994-03-22
DK0562877T3 (da) 2000-07-31
US5597688A (en) 1997-01-28
JP3651912B2 (ja) 2005-05-25
US5422277A (en) 1995-06-06
EP0562877A2 (de) 1993-09-29
EP0562877B1 (de) 2000-06-14

Similar Documents

Publication Publication Date Title
DE69328846T2 (de) Zellfixierungsmittel und Verfahren zum Anfärben von Zellen ohne Vernichtung der Zelloberfläche
ATE248150T1 (de) Lactam-enthaltende hydroxamsäure-derivate, deren herstellung und deren verwendung als inhibitoren von matrix-metalloproteasen
EA199700343A1 (ru) Микрокапсулы, содержащие суспензии биологически активных соединений, и средство защиты от ультрафиолетового света
TR199902426T2 (xx) Bitki b�ceklerinin kontrol�.
ATE223374T1 (de) Lipidverbindungen
DE3785602T2 (de) Verwendung von a-, b- und c-prostaglandinen und deren derivaten zur behandlung von augen-hypertension und glaukom.
DE69325948D1 (de) Entfernung von Antikörpern aus von Blut stammenden Zusammensetzungen unter Erhalt von Gerinnungsfaktoren
DE69524663D1 (de) Verwendung von Extracten aus filamentösen Bakterien als kosmetische Mittel gegen Hautaltern
DE3774858D1 (de) Derivate von n-(2-alkyl-3-mercaptoglutaryl)-alpha-aminosaeuren und deren verwendung als collagenase-inhibitoren.
ATE228765T1 (de) Zusammensetzung und verfahren zur behandlung von pflanzen mit exogenen chemikalien
ATE97791T1 (de) Vorrichtung zur bestimmung der konzentration von zumindest einer in organischem gewebe vorliegenden substanz.
ATA189793A (de) Lösung zur perfusion, konservierung und reperfusion von organen
ATE188337T1 (de) Verfahren zur herstellung von verbesserten biologischen pestiziden
DE3677092D1 (de) Emulsionen zur entseuchung giftiger, chemischer mittel, deren herstellung und verwendung.
DE59708046D1 (de) Verfahren zur Herstellung von Celluloselösungen in wasserhaltigem Aminoxid
GR1003056B (el) Στερεωτικο κυτταρων και μεθοδος χρωματισμου κυτταρων χωρις καταστροφη της επιφανειας των κυτταρων.
DE58908064D1 (de) N-substituierte Benzimidazol-2-carbonsäureanilide, deren Verwendung als Lichtschutzmittel, insbesondere Polymere und diese Anilide enthaltendes organisches Material.
ATE3974T1 (de) Verfahren zur herstellung von 4,4'-dinitrostilben-2,2'-disulfonsaeure und deren salzen und deren verwendung.
ATE41940T1 (de) Wasserloesliche copolymerisate und deren verwendung als baustoffhilfsmittel.
ATE190492T1 (de) Verwendung von gift aus hautflüglern (hymenopteren) zur herstellung eines medikamentes zur behandlung von infektionen durch dna-viren
ES2075299T3 (es) Derivados substituidos de amidas de aminoacidos su obtencion y su empleo.
DE68916211D1 (de) Guanidin- und Amidin-Verbindungen, deren Herstellung und Verwendung als Fungizide.
DE59000985D1 (de) Verwendung von monocarbonsaeurepolyoxyalkylester -sulfonaten als schaumarme textilbehandlungsmittel.
DE69103425D1 (de) Verfahren zur verhinderung der zerstörung von meerwasserzellen durch biologische verschmutzung.
PT65644B (de) Verfahren zur herstellung von 1,3-gleichsubstituierten triazin-2,4-dionen sowie deren verwendung als insektizide

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN